Study to Assess the Safety and Pharmacokinetics of ATL-001 (Ciclopirox Olamine) in Healthy Volunteers

Clinical trial NCT05647343 · COMPLETED

Trial details

NCT number: NCT05647343
Sponsor: Atlas Molecular Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Adverse Effect of Drugs and Medicaments in Therapeutic Use

Start date: 2023-03-31
Primary completion: 2024-04-08
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.